Literature DB >> 3940238

Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats.

E Baraona, R Julkunen, L Tannenbaum, C S Lieber.   

Abstract

To investigate the role of intestinal bacterial overgrowth on the production and metabolism of ethanol, rats with a jejunal self-filling diverticulum (blind-loop) were compared to controls with a self-emptying diverticulum. Both endogenous ethanol and acetaldehyde were found in the blind-loop contents. Intragastric administration of sucrose produced a marked increase in acetaldehyde and acetate in the portal venous blood, with only a modest elevation of ethanol. Blind-loop contents readily oxidized ethanol to acetaldehyde in a concentration-dependent manner and more actively under aerobic than anaerobic conditions. This oxidation was inhibited by antibiotics and was reproduced with isolated microorganisms. Intragastric administration of ethanol to rats with blind-loops markedly increased acetaldehyde and acetate concentrations in the portal vein and, to a lesser extent, in the systemic blood, compared with the controls. By contrast, both portal and systemic blood ethanol concentrations were lower in the rats with a blind-loop compared with controls, even though the amounts of ethanol retained in the digestive tract were similar. A dose of ethanol about twice as large as in controls was required to produce similar systemic blood levels. Both in rats with a blind-loop and in the controls, the areas under the curve of blood ethanol concentrations were smaller after intragastric than after intravenous ethanol administration (1 g ethanol/kg body wt). This difference was exaggerated in the rats with a blind-loop. Thus, a considerable amount of ethanol is oxidized in the gastrointestinal lumen of rats with a blind-loop. The resulting high concentrations of acetaldehyde, both in the intestinal lumen and the portal blood, may have deleterious effects on the gastrointestinal mucosa and the liver.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940238     DOI: 10.1016/0016-5085(86)90081-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

1.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

2.  Effect of 8-weeks prebiotics/probiotics supplementation on alcohol metabolism and blood biomarkers of healthy adults: a pilot study.

Authors:  Christopher Irwin; Saman Khalesi; Amanda J Cox; Gary Grant; Andrew K Davey; Andrew C Bulmer; Ben Desbrow
Journal:  Eur J Nutr       Date:  2017-03-19       Impact factor: 5.614

3.  Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD).

Authors:  Valentina Volynets; Markus A Küper; Stefan Strahl; Ina B Maier; Astrid Spruss; Sabine Wagnerberger; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Dig Dis Sci       Date:  2012-03-17       Impact factor: 3.199

4.  Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents.

Authors:  Laurent Ferrier; Florian Bérard; Laurent Debrauwer; Chantal Chabo; Philippe Langella; Lionel Buéno; Jean Fioramonti
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

5.  High intracolonic acetaldehyde values produced by a bacteriocolonic pathway for ethanol oxidation in piglets.

Authors:  K Jokelainen; T Matysiak-Budnik; H Mäkisalo; K Höckerstedt; M Salaspuro
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

6.  Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.

Authors:  Irina A Kirpich; Joseph Petrosino; Nadim Ajami; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Shirish S Barve; Xinmin Yin; Xiaoli Wei; Xiang Zhang; Craig J McClain
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

7.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

8.  Response of the jejunal mucosa of dogs with aerobic and anaerobic bacterial overgrowth to antibiotic therapy.

Authors:  R M Batt; L McLean; J E Riley
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

9.  Role of alcohol metabolism in non-alcoholic steatohepatitis.

Authors:  Susan S Baker; Robert D Baker; Wensheng Liu; Norma J Nowak; Lixin Zhu
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

10.  Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes.

Authors:  B J Novak; D R Blake; S Meinardi; F S Rowland; A Pontello; D M Cooper; P R Galassetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.